Kornitzer Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-113,400
Closed -$1.98M 515
2020
Q4
$1.98M Hold
113,400
0.03% 349
2020
Q3
$1.33M Hold
113,400
0.03% 370
2020
Q2
$1.47M Hold
113,400
0.03% 361
2020
Q1
$1.05M Buy
113,400
+32,500
+40% +$454K 0.02% 375
2019
Q4
$1.34M Hold
80,900
0.02% 379
2019
Q3
$1.34M Hold
80,900
0.02% 365
2019
Q2
$1.11M Hold
80,900
0.02% 386
2019
Q1
$1.39M Hold
80,900
0.03% 350
2018
Q4
$1.03M Hold
80,900
0.02% 373
2018
Q3
$1.31M Hold
80,900
0.02% 365
2018
Q2
$1.04M Hold
80,900
0.02% 374
2018
Q1
$1.01M Buy
80,900
+20,600
+34% +$251K 0.02% 381
2017
Q4
$842K Hold
60,300
0.01% 399
2017
Q3
$1.01M Hold
60,300
0.02% 381
2017
Q2
$1.01M Hold
60,300
0.02% 383
2017
Q1
$934K Sell
60,300
-16,200
-21% -$231K 0.02% 378
2016
Q4
$1.14M Sell
76,500
-21,000
-22% -$295K 0.02% 361
2016
Q3
$1.23M Sell
97,500
-6,200
-6% -$62.2K 0.02% 346
2016
Q2
$933K Buy
103,700
+19,100
+23% +$187K 0.02% 367
2016
Q1
$838K Sell
84,600
-360
-0.4% -$3.69K 0.01% 371
2015
Q4
$977K Sell
84,960
-42,340
-33% -$524K 0.02% 364
2015
Q3
$1.72M Sell
127,300
-9,100
-7% -$123K 0.03% 328
2015
Q2
$1.89M Sell
136,400
-117,169
-46% -$1.58M 0.03% 330
2015
Q1
$3.57M Hold
253,569
0.04% 283
2014
Q4
$3.45M Buy
253,569
+67,671
+36% +$925K 0.04% 281
2014
Q3
$2.84M Buy
185,898
+113,710
+158% +$1.74M 0.03% 292
2014
Q2
$1.22M Hold
72,188
0.01% 333
2014
Q1
$1.45M Sell
72,188
-80,424
-53% -$1.74M 0.02% 339
2013
Q4
$2.96M Buy
+152,612
New +$2.7M 0.03% 302

Kornitzer Capital Management's OXFD Position: Q1 2021 in Review

Kornitzer Capital Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 113,400 shares — an estimated $1.98M sold.

Kornitzer Capital Management first reported a position in OXFD in Q4 2013 and held it in 29 quarters. The position peaked at $3.57M in Q1 2015. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

  • Kornitzer Capital Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Kornitzer Capital Management sold 113,400 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $1.98M.
  • Kornitzer Capital Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 29 quarters.
  • Kornitzer Capital Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $3.57M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Kornitzer Capital Management's 13F filing for Q1 2021, filed 30 Apr 2021.